Changes in epidemiology and clinical practice in IgE-mediated Allergy in children

Escarrer-Jaume, Mercedes; Juliá-Benito, Juan Carlos; Quevedo-Teruel, Sergio; Prado, Ana Prieto del; Sandoval‐Ruballos, Mónica; Quesada-Sequeira, Fabriella; Alvaro‐Lozano, Montserrat

doi:10.1016/j.anpede.2021.04.002

Cited by 3 publications

(2 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, nanotechnology-based optical biosensors, such as gold nanoclusters, have significant potential in ensuring food safety by detecting harmful pathogens and chemical substances [ 91 ]. In the context of food allergies and anaphylaxis, nanotechnology-based diagnostic methods can enable personalized allergen immunotherapy and avoidance diets to effectively manage the increasing prevalence of food allergies [ 92 ]. To drive progress in this field, collaborative efforts among food producers, policy makers, and health authorities are necessary to address safety concerns and provide adequate funding for research.…”

Section: Nanotechnology In Other Pediatric Related Areasmentioning

confidence: 99%

“…Nanotechnology-based optical biosensors enhance food safety by enabling the rapid and accurate detection of harmful contaminants [ 91 ]. Additionally, nanotechnology-based diagnostics aid in personalized allergen immunotherapy, ensuring safer and more effective management of food allergies in children [ 92 ]. Collaborative efforts are crucial for advancing research and ensuring the safety and efficacy of nanotechnology in the field of pediatric nutrition [ 88 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions

Omidian

Mfoafo

2023

Pharmaceutics

View full text Add to dashboard Cite

The utilization of nanotechnology has brought about notable advancements in the field of pediatric medicine, providing novel approaches for drug delivery, disease diagnosis, and tissue engineering. Nanotechnology involves the manipulation of materials at the nanoscale, resulting in improved drug effectiveness and decreased toxicity. Numerous nanosystems, including nanoparticles, nanocapsules, and nanotubes, have been explored for their therapeutic potential in addressing pediatric diseases such as HIV, leukemia, and neuroblastoma. Nanotechnology has also shown promise in enhancing disease diagnosis accuracy, drug availability, and overcoming the blood–brain barrier obstacle in treating medulloblastoma. It is important to acknowledge that while nanotechnology offers significant opportunities, there are inherent risks and limitations associated with the use of nanoparticles. This review provides a comprehensive summary of the existing literature on nanotechnology in pediatric medicine, highlighting its potential to revolutionize pediatric healthcare while also recognizing the challenges and limitations that need to be addressed.

show abstract

Section: Nanotechnology In Other Pediatric Related Areasmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions

Omidian

Mfoafo

2023

Pharmaceutics

View full text Add to dashboard Cite

show abstract

Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma

Ahmad

2022

Life

View full text Add to dashboard Cite

With a high prevalence globally, asthma is a severe hazard to human health, as well as an economic and social burden. There are now novel therapies available for asthma with the use of nanotechnology. Recent developments in nanoscience and medicine have encouraged the creation of inhalable nanomedicines that can enhance the efficacy, patient compliance, and life quality for sufferers of asthma. Nanocarriers for asthma therapy, including liposomes, micelles, polymers, dendrimers, and inorganics, are presented in depth in this study as well as the current research status of these nanocarriers. Aerosolized nanomaterial-based drug transport systems are currently being developed, and some examples of these systems, as well as prospective future paths, are discussed. New research subjects include nano-modification of medicines and the development of innovative nano-drugs. Clinical experiments have proven that nanocarriers are both safe and effective. Before nanotherapy can be applied in clinical practice, several obstacles must be addressed. We look at some of the most recent research discoveries in the subject of nanotechnology and asthma therapy in this article.

show abstract

Tropomyosins of the helminthes: Sensitization and association with allergic diseases

Rovitskaya

Федорова

Камалтынова

2023

Russian Journal of Allergy

View full text Add to dashboard Cite

The growth of the prevalence of allergic diseases has been a driver for the development of new technologies: over the past two decades, significant progress in biochemistry and molecular allergology has contributed to the study of the structure of allergens and the development of component-resolved diagnostics. In particular, clinically significant families of allergens have been identified, including tropomyosin, which can cause a wide range of cross-IgE-mediated reactions. One of the risk factors for the sensitization development are helminthiases, which are common in different regions, there forein the population of endemic areas. The global prevalence of helminthiasis remains high: it is estimated that 1.5 billion people worldwide are chronically infected with at least one helminth. The purpose of this review is to analyze current studies aimed at determining the relationship between helminth infections and the development of sensitization to helminth tropomyosin and the clinical course of allergic diseases. Methods: Analysis of scientific publications described the relationship between helminths tropomyosin and the development of allergic diseases and sensitization in patients with parasitic infection. We used the PubMed database for the review. The review presents original articles published for a period from January 1, 2000 to December 31, 2021

show abstract

Changes in epidemiology and clinical practice in IgE-mediated Allergy in children

Cited by 3 publications

References 38 publications

Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions

Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions

Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma

Tropomyosins of the helminthes: Sensitization and association with allergic diseases

Contact Info

Product

Resources

About